Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
CNTNCanton Strategic Holdings	$231.83m	n/a	n/a
KROSKeros Therapeutics	$230.89m	4.93	n/a
IKTInhibikase Therapeutics	$228.50m	n/a	n/a
SLRNAcelyrin	$227.15m	n/a	n/a
MACKMerrimack Pharmaceuticals	$223.75m	n/a	n/a
SLGLSol Gel Technologies	$220.08m	n/a	n/a
CRGXCARGO Therapeutics	$219.57m	n/a	n/a
ALECAlector	$218.52m	n/a	n/a
VYGRVoyager Therapeutics	$218.51m	n/a	n/a
SPPISpectrum Pharmaceuticals	$211.40m	n/a	n/a
HUMAHumacyte	$210.37m	n/a	n/a
ELDNEledon Pharmaceuticals	$207.60m	n/a	n/a
ELTXElicio Therapeutics	$206.73m	n/a	n/a
ARCTArcturus Therapeutics Holdings	$206.07m	n/a	n/a
ABOSAcumen Pharmaceuticals	$202.32m	n/a	n/a
QSIQuantum-Si	$196.79m	n/a	n/a
GALTGalectin Therapeutics	$195.35m	n/a	n/a
CGENCompugen	$193.84m	n/a	n/a
HRTXHeron Therapeutics	$192.31m	n/a	n/a
EDITEditas Medicine	$184.99m	n/a	n/a